Your browser doesn't support javascript.
loading
Differential Effects of Comorbid Psychiatric Disorders on Treatment Outcome in Posttraumatic Stress Disorder from Childhood Trauma.
Assmann, Nele; Fassbinder, Eva; Schaich, Anja; Lee, Christopher W; Boterhoven de Haan, Katrina; Rijkeboer, Marleen; Arntz, Arnoud.
Afiliación
  • Assmann N; Department of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
  • Fassbinder E; Department of Psychiatry and Psychotherapy, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
  • Schaich A; Department of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
  • Lee CW; Department of Psychiatry and Psychotherapy, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
  • Boterhoven de Haan K; Department of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
  • Rijkeboer M; Department of Psychiatry and Psychotherapy, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
  • Arntz A; Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA 6009, Australia.
J Clin Med ; 10(16)2021 Aug 20.
Article en En | MEDLINE | ID: mdl-34442005
ABSTRACT
Patients with posttraumatic stress disorder (PTSD) frequently have comorbid diagnoses such as major depressive disorder (MDD) and anxiety disorders (AD). Studies into the impact of these comorbidities on the outcome of PTSD treatment have yielded mixed results. The different treatments investigated in these studies might explain the varied outcome. The purpose of this study was to examine the impact of these comorbidities on the outcome of two specific PTSD treatments. MDD and AD were analyzed as predictors and moderators in a trial comparing 12 sessions of either eye movement desensitization and reprocessing (EMDR) or imagery rescripting (IR) in 155 adult patients with PTSD from childhood trauma. The primary outcome was reduction of PTSD symptoms (clinician-administered PTSD Scale for DSM-5, CAPS-5) assessed at eight-week follow-up and a secondary outcome was self-report PTSD symptoms (Impact of Event Scale, IES-R). MDD was not a predictor of treatment outcome but did have a significant moderator effect. Patients with MDD showed a better outcome if they were treated with IR, whereas patients without MDD improved more in the EMDR condition. No impact of AD emerged. It seems essential to consider comorbid MDD when planning PTSD treatment to improve treatment outcomes. More research is needed to replicate our findings and focus on different kinds of PTSD treatments and other comorbidities.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2021 Tipo del documento: Article